Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises SEB Kort Bank AB in connection with its acquisition of Lufthansa AirPlus Servicekarten GmbH
Mandate

Vinge advises SEB Kort Bank AB in connection with its acquisition of Lufthansa AirPlus Servicekarten GmbH

June 21, 2023 M&A

SEB Kort Bank AB ("SEB Kort"), a wholly-owned subsidiary within the SEB Group, has entered into an agreement with Lufthansa Group to acquire all shares in Lufthansa AirPlus Servicekarten GmbH ("AirPlus").

Together, SEB Kort and AirPlus will become a leading European player in the corporate payments sector. For a cash consideration of EUR 450 million, the transaction will provide SEB Kort with additional scale, a strong position for further growth in Europe, and a modern IT platform. In addition, the transaction is expected to result in synergies and also complement SEB's broader ambitions in the corporate business in the DACH region (Germany, Austria, and Switzerland) and northern Europe.

In connection with the transaction, Vinge has acted as local counsel for SEB Kort and assisted with Swedish corporate and regulatory matters.

The transaction is, inter alia, subject to approvals from governmental authorities.

Vinge's team consisted of Daniel Rosvall and Viktor Lennartsson (M&A) as well as Caroline Krassén (Financial Services).

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026